Filana Therapeutics FLNA
NASDAQ FLNA
$0.66 -0.03 (-4.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Filana Therapeutics' Liabilities and Shareholders Equity came in at $103.9 million for Q2 2026, down 23.3% from $135.38 million a year earlier and down 4.1% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Filana Therapeutics' Liabilities and Shareholders Equity was $118.36 million, down 24.9% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $157.53 million in FY2024 (+3.9%), $151.66 million in FY2023 (-35.4%), $234.83 million in FY2022 (-12.0%) and $266.78 million in FY2021 (+182.9%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2020.
  • Year-over-year, Liabilities and Shareholders Equity has declined for six consecutive quarters, with an average decline of 16.7% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2021 (growth of 979.8%), and the weakest in Q2 2025 (a decline of 44.4%).
  • Business Quant data shows FLNA's Liabilities and Shareholders Equity at $108.37 million (Q1 2026), $118.36 million (Q4 2025) and $129.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Filana Therapeutics 32.11 Mn -338.73 Mn - 103.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103.90 Mn
Mar 31, 2026 108.37 Mn
Dec 31, 2025 118.36 Mn
Sep 30, 2025 129.73 Mn
Jun 30, 2025 135.38 Mn
Mar 31, 2025 140.93 Mn
Dec 31, 2024 157.53 Mn
Sep 30, 2024 223.75 Mn
Jun 30, 2024 243.57 Mn
Mar 31, 2024 155.72 Mn
Dec 31, 2023 151.66 Mn
Sep 30, 2023 172.53 Mn
Jun 30, 2023 197.25 Mn
Mar 31, 2023 218.11 Mn
Dec 31, 2022 234.83 Mn
Sep 30, 2022 207.29 Mn
Jun 30, 2022 227.38 Mn
Mar 31, 2022 244.19 Mn
Dec 31, 2021 266.78 Mn
Sep 30, 2021 274.25 Mn
API Access

Filana Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=FLNA&period=max&api_key=YOUR_API_KEY